Plain-English translation of NCT06479577 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing two different physical therapies—therapeutic ultrasound and high-intensity laser therapy—to help reduce nerve pain in the feet of people with type 2 diabetes. Both treatments will be used alongside routine physical therapy. The researchers want to understand whether one of these treatments works better than the other for easing pain, improving foot strength, and enhancing daily quality of life.
Many people with long-standing diabetes develop painful nerve damage in their feet, which significantly impacts their ability to walk and enjoy life. While these physical treatments are sometimes used, there is limited research comparing them directly, so doctors don't yet know which approach works best for this problem.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to receive either therapeutic ultrasound or high-intensity laser therapy sessions, each lasting about 20 minutes. You will receive these treatments alongside your regular physical therapy. The researchers will measure your pain levels, foot strength, and quality of life before, during, and after the treatment period to see which approach helps you most.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Pakistan
Sponsor
Riphah International University
Enrollment target
~46 participants
Started
February 2024
Primary completion
July 2024
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
50 Years – 75 Years
Last updated on clinicaltrials.gov in June 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Imran Amjad, Phd
Riphah International University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.